Literature DB >> 11260060

Pathogenetic analysis of three cases with a bleeding disorder characterized by defective platelet aggregation induced by Ca2+ ionophores.

I Fuse1, W Higuchi, Y Uesugi, Y Aizawa.   

Abstract

We report three cases of platelet dysfunction characterized by defective Ca2+ ionophore-induced platelet aggregation without impaired production of thromboxane A2 (TXA2). The patients had mild to moderate bleeding tendencies, and their platelet aggregation and secretion induced by ADP, collagen, arachidonic acid, stable TXA2 (STA2) and Ca2+ ionophore A23187 was defective or much reduced. However, ristocetin- or thrombin-induced platelet aggregation was normal. The analysis of second messenger formation showed that inositol 1,4,5-triphosphate formation or Ca2+ mobilization induced by thrombin, STA2 or A23187 was normal. Furthermore, the phosphorylation of 47 kDa protein (pleckstrin) and 20 kDa protein (myosin light chain, MLC) in response to those agonists was normal. These findings suggest that the defective site in the patients' platelets lies in the process distal to or independent of protein kinase C activation, Ca2+ mobilization and MLC phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11260060     DOI: 10.1046/j.1365-2141.2001.02637.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A(2) synthesis and calcium entry.

Authors:  Heng-Lan Kuo; Jin-Cherng Lien; Chien-Hsin Chang; Ching-Hu Chung; Sheng-Chu Kuo; Chun-Chieh Hsu; Hui-Chin Peng; Tur-Fu Huang
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

2.  Dual mechanism of integrin αIIbβ3 closure in procoagulant platelets.

Authors:  Nadine J A Mattheij; Karen Gilio; Roger van Kruchten; Shawn M Jobe; Adam J Wieschhaus; Athar H Chishti; Peter Collins; Johan W M Heemskerk; Judith M E M Cosemans
Journal:  J Biol Chem       Date:  2013-03-21       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.